MX2019002495A - Metodos para producir virus para la produccion de vacunas. - Google Patents

Metodos para producir virus para la produccion de vacunas.

Info

Publication number
MX2019002495A
MX2019002495A MX2019002495A MX2019002495A MX2019002495A MX 2019002495 A MX2019002495 A MX 2019002495A MX 2019002495 A MX2019002495 A MX 2019002495A MX 2019002495 A MX2019002495 A MX 2019002495A MX 2019002495 A MX2019002495 A MX 2019002495A
Authority
MX
Mexico
Prior art keywords
methods
vaccine production
producing virus
enterovirus
virus
Prior art date
Application number
MX2019002495A
Other languages
English (en)
Inventor
Rao Raman
Sato Tatsuki
Oda Kaori
Nakamura Kuniaki
Nishihama Takeshi
Original Assignee
Takeda Vaccines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Vaccines Inc filed Critical Takeda Vaccines Inc
Publication of MX2019002495A publication Critical patent/MX2019002495A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32351—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32651—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

La presente divulgación se refiere a métodos para producir Enterovirus C, p. ej. ,para la producción de vacunas de poliomelitis. En algunas modalidades, los métodos incluyen agregar polisorbatos al medio de cultivo celular durante o antes de la inoculación con el virus y/o cultivar células en un biorreactor de lecho fijo. En la presente también se proporciona un Enterovirus C producido por lo métodos de producción divulgados en la presente, así como composiciones, composiciones inmunogénicas y vacunas relacionadas con este.
MX2019002495A 2016-09-01 2017-09-01 Metodos para producir virus para la produccion de vacunas. MX2019002495A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662382621P 2016-09-01 2016-09-01
PCT/US2017/049956 WO2018045344A1 (en) 2016-09-01 2017-09-01 Methods for producing virus for vaccine production

Publications (1)

Publication Number Publication Date
MX2019002495A true MX2019002495A (es) 2020-02-17

Family

ID=61301648

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019002495A MX2019002495A (es) 2016-09-01 2017-09-01 Metodos para producir virus para la produccion de vacunas.

Country Status (12)

Country Link
US (1) US20190194628A1 (es)
EP (1) EP3506939A4 (es)
JP (1) JP2019532624A (es)
KR (1) KR20190042606A (es)
CN (1) CN109689092A (es)
AR (1) AR109564A1 (es)
AU (1) AU2017318714A1 (es)
BR (1) BR112019004187A2 (es)
CA (1) CA3034269A1 (es)
MX (1) MX2019002495A (es)
SG (1) SG11201901518WA (es)
WO (1) WO2018045344A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9677042B2 (en) 2010-10-08 2017-06-13 Terumo Bct, Inc. Customizable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
EP3068867B1 (en) 2013-11-16 2018-04-18 Terumo BCT, Inc. Expanding cells in a bioreactor
JP6783143B2 (ja) 2014-03-25 2020-11-11 テルモ ビーシーティー、インコーポレーテッド 培地の受動的補充
WO2016049421A1 (en) 2014-09-26 2016-03-31 Terumo Bct, Inc. Scheduled feed
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
JP7393945B2 (ja) 2017-03-31 2023-12-07 テルモ ビーシーティー、インコーポレーテッド 細胞増殖
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
SG11202007503WA (en) * 2018-02-07 2020-09-29 Bharat Biotech Int Ltd A process for enterovirus purification and inactivation and vaccine compositions obtained thereof
EP4262863A1 (en) * 2020-12-17 2023-10-25 Merck Sharp & Dohme LLC Enterovirus purification with cation exchange chromatography
CN114594257B (zh) * 2022-05-09 2022-08-05 北京生物制品研究所有限责任公司 含CpG ODN的吸附型疫苗的解吸附组合物及其应用
WO2024017827A1 (en) * 2022-07-19 2024-01-25 Glaxosmithkline Biologicals Sa Continuous process for vaccine production

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737730B1 (fr) * 1995-08-10 1997-09-05 Pasteur Merieux Serums Vacc Procede de purification de virus par chromatographie
CN1297313C (zh) * 2004-09-16 2007-01-31 中国医学科学院医学生物学研究所 减毒株脊髓灰质炎灭活疫苗后处理方法
CN102257134B (zh) * 2008-02-12 2014-03-05 赛诺菲巴斯德有限公司 使用离子交换和凝胶过滤色谱进行痘病毒纯化的方法
CN102078605B (zh) * 2010-12-27 2013-11-06 吉林亚泰生物药业股份有限公司 Vero细胞流感病毒疫苗制备方法
JOP20130186B1 (ar) * 2012-06-22 2021-08-17 Takeda Vaccines Montana Inc تنقية الجزيئات الشبيهة بالفيروسات
US20150056244A1 (en) * 2013-08-25 2015-02-26 Sentinext Therapeutics Sdn Bhd Antigens and Vaccines Directed Against Human Enteroviruses
CA2955877A1 (en) * 2014-07-24 2016-01-28 Janssen Vaccines & Prevention B.V. Process for the purification of poliovirus from cell cultures
JPWO2016093251A1 (ja) * 2014-12-08 2017-05-25 旭化成メディカル株式会社 生理活性物質の精製方法
MA41506A (fr) * 2015-02-13 2017-12-19 Takeda Vaccines Inc Procédés de production de virus pour produire des vaccins

Also Published As

Publication number Publication date
EP3506939A4 (en) 2020-04-08
SG11201901518WA (en) 2019-03-28
US20190194628A1 (en) 2019-06-27
BR112019004187A2 (pt) 2019-06-25
EP3506939A1 (en) 2019-07-10
CN109689092A (zh) 2019-04-26
KR20190042606A (ko) 2019-04-24
JP2019532624A (ja) 2019-11-14
AR109564A1 (es) 2018-12-26
CA3034269A1 (en) 2018-03-08
WO2018045344A1 (en) 2018-03-08
AU2017318714A1 (en) 2019-03-21

Similar Documents

Publication Publication Date Title
MX2019002495A (es) Metodos para producir virus para la produccion de vacunas.
PH12017501445A1 (en) Methods for producing virus for vaccine production
MX2011013178A (es) Produccion de etanol mediante fermentacion.
EP3372685A3 (en) Cell lines for virus production and methods of use
MY163081A (en) Animal cell culturing method
BR112017021255A2 (pt) microrganismo modificado para a produção otimizada de 2,4-di-hidroxibutirato
BR112016007919A2 (pt) vacinas atenuadas vivas
AR093398A1 (es) PROPAGACION DE LEVADURA A UN pH CONTROLADO
MY193954A (en) Method for manufacturing ciliary margin stem cells
MX2009007354A (es) Proceso para producir biomasa y proteinas mediante microalgas.
WO2017051347A3 (en) Cells and method of cell culture
MX2018006627A (es) Aumentar el rendimiento de particulas similares a virus en plantas.
MX2021009554A (es) Produccion de virus en cultivos celulares.
NZ611531A (en) Bovine viral diarrhea virus type 1b vaccine compositions and methods
MX2020001357A (es) Produccion microbiana de aminas grasas.
BR112016005456A2 (pt) método para produzir um l-aminoácido por um método de fermentação, e, dna isolado
EA201690232A1 (ru) Генетически стабильный онколитический рнк вирус, способ его производства и применения
MY173418A (en) Method of producing japanese encephalitis avccines stably storable over long time and use of the vaccine
BR112018002284A2 (pt) método de fermentação para produzir um bioproduto, levedura crabtree negativa geneticamente engenheirada e método para reduzir a produção de glicerol por uma levedura engenheirada
SG11201806843UA (en) Method for producing activated hepatocyte growth factor (hgf)
MY182418A (en) Ibe fermentation method
FI20175668A (fi) Menetelmä betulaceae-perheen soluviljelmien tuottamiseksi, mainittuja soluviljelmiä käsittävät koostumukset ja mainittujen soluviljelmien käyttö
BR112015021772A2 (pt) método para a preparação de células embrionárias aviárias, método melhorado para a preparação de células embrionárias aviárias a partir de um embrião, cultura ou composição de células embrionárias aviárias, método para a produção ou amplificação de um vírus, e, composição de vacina
FR3027030B1 (fr) Utilisation de biofilms bacteriens en oenologie
BR112017021306A2 (pt) microrganismo modificado para a produção otimizada de 2,4-di- hidroxibutirato com efluxo de 2,4-di-hidroxibutirato intensificado